{"id":"https://openalex.org/W4390946007","doi":"https://doi.org/10.3390/molecules29020454","title":"Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy","display_name":"Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy","publication_year":2024,"publication_date":"2024-01-17","ids":{"openalex":"https://openalex.org/W4390946007","doi":"https://doi.org/10.3390/molecules29020454","pmid":"https://pubmed.ncbi.nlm.nih.gov/38257366","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10819708"},"language":"en","primary_location":{"id":"doi:10.3390/molecules29020454","doi":"https://doi.org/10.3390/molecules29020454","is_oa":true,"landing_page_url":"https://doi.org/10.3390/molecules29020454","pdf_url":"https://www.mdpi.com/1420-3049/29/2/454/pdf?version=1705484570","source":{"id":"https://openalex.org/S108911230","display_name":"Molecules","issn_l":"1420-3049","issn":["1420-3049","1433-1373"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecules","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1420-3049/29/2/454/pdf?version=1705484570","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059703866","display_name":"Qiaohong Geng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097715","display_name":"Qilu Normal University","ror":"https://ror.org/00wztsq19","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210097715"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qiaohong Geng","raw_affiliation_strings":["School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China","institution_ids":["https://openalex.org/I4210097715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031760573","display_name":"Peifu Jiao","orcid":"https://orcid.org/0000-0003-4255-6499","observed_orcids":["https://orcid.org/0000-0003-4255-6499"]},"institutions":[{"id":"https://openalex.org/I4210097715","display_name":"Qilu Normal University","ror":"https://ror.org/00wztsq19","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210097715"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Peifu Jiao","raw_affiliation_strings":["School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China","institution_ids":["https://openalex.org/I4210097715"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031760573","https://openalex.org/A5059703866"],"corresponding_institution_ids":["https://openalex.org/I4210097715"],"apc_list":{"value":2700,"currency":"CHF","value_usd":3069},"apc_paid":{"value":2700,"currency":"CHF","value_usd":3069},"fwci":0.9246,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.70714614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"29","issue":"2","first_page":"454","last_page":"454"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/co-inhibitory-molecules","display_name":"co-inhibitory molecules","score":0.9319999814033508},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9779999852180481},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pd-l2","display_name":"PD-L2","score":0.843999981880188},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cd28","display_name":"CD28","score":0.8960000276565552},{"id":"https://openalex.org/keywords/cd27","display_name":"CD27","score":0.8389999866485596},{"id":"https://openalex.org/keywords/ox40","display_name":"OX40","score":0.9990000128746033},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.9940000176429749},{"id":"https://openalex.org/keywords/inducible-t-cell-costimulator","display_name":"ICOS","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5540000200271606},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5839999914169312},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5590000152587891},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.788913369178772},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.6809536218643188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6662035584449768},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6516298651695251},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5417888760566711},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.526196300983429},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5201040506362915},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5159350037574768},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5135893821716309},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.49979114532470703},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41830331087112427},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3504061698913574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3483738303184509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32282280921936035},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31924283504486084}],"mesh":[{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3390/molecules29020454","doi":"https://doi.org/10.3390/molecules29020454","is_oa":true,"landing_page_url":"https://doi.org/10.3390/molecules29020454","pdf_url":"https://www.mdpi.com/1420-3049/29/2/454/pdf?version=1705484570","source":{"id":"https://openalex.org/S108911230","display_name":"Molecules","issn_l":"1420-3049","issn":["1420-3049","1433-1373"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecules","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10819708","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10819708","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10819708/pdf/molecules-29-00454.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecules","raw_type":"Text"},{"id":"pmid:38257366","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38257366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecules (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:07ab49a7fbab4a5f8776ac178822811e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/07ab49a7fbab4a5f8776ac178822811e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecules, Vol 29, Iss 2, p 454 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/molecules29020454","doi":"https://doi.org/10.3390/molecules29020454","is_oa":true,"landing_page_url":"https://doi.org/10.3390/molecules29020454","pdf_url":"https://www.mdpi.com/1420-3049/29/2/454/pdf?version=1705484570","source":{"id":"https://openalex.org/S108911230","display_name":"Molecules","issn_l":"1420-3049","issn":["1420-3049","1433-1373"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecules","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6410225285","display_name":null,"funder_award_id":"ZR2020MB013","funder_id":"https://openalex.org/F4320324174","funder_display_name":"Natural Science Foundation of Shandong Province"},{"id":"https://openalex.org/G7087752198","display_name":null,"funder_award_id":"ZR2020MB106","funder_id":"https://openalex.org/F4320324174","funder_display_name":"Natural Science Foundation of Shandong Province"}],"funders":[{"id":"https://openalex.org/F4320324174","display_name":"Natural Science Foundation of Shandong Province","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390946007.pdf","grobid_xml":"https://content.openalex.org/works/W4390946007.grobid-xml"},"referenced_works_count":120,"referenced_works":["https://openalex.org/W4674812","https://openalex.org/W75602434","https://openalex.org/W1484684540","https://openalex.org/W1511162210","https://openalex.org/W1528911741","https://openalex.org/W1538902372","https://openalex.org/W1564765245","https://openalex.org/W1568317937","https://openalex.org/W1590618281","https://openalex.org/W1616189793","https://openalex.org/W1661441964","https://openalex.org/W1862469320","https://openalex.org/W1942897646","https://openalex.org/W1967687807","https://openalex.org/W1974428835","https://openalex.org/W1976549140","https://openalex.org/W1980802782","https://openalex.org/W1983626365","https://openalex.org/W1988474688","https://openalex.org/W1992249154","https://openalex.org/W2001287101","https://openalex.org/W2003896199","https://openalex.org/W2013165543","https://openalex.org/W2013177587","https://openalex.org/W2016983859","https://openalex.org/W2018710900","https://openalex.org/W2023776610","https://openalex.org/W2026893575","https://openalex.org/W2032743253","https://openalex.org/W2036813682","https://openalex.org/W2037708347","https://openalex.org/W2046409157","https://openalex.org/W2046739604","https://openalex.org/W2050457398","https://openalex.org/W2051870875","https://openalex.org/W2060070314","https://openalex.org/W2065684180","https://openalex.org/W2068047393","https://openalex.org/W2070668733","https://openalex.org/W2086397613","https://openalex.org/W2089233870","https://openalex.org/W2094366129","https://openalex.org/W2107752337","https://openalex.org/W2117716734","https://openalex.org/W2118471749","https://openalex.org/W2128758225","https://openalex.org/W2130473166","https://openalex.org/W2145857936","https://openalex.org/W2147360261","https://openalex.org/W2149748445","https://openalex.org/W2155464214","https://openalex.org/W2162472186","https://openalex.org/W2296047035","https://openalex.org/W2302088846","https://openalex.org/W2338264038","https://openalex.org/W2395845086","https://openalex.org/W2403400382","https://openalex.org/W2523826139","https://openalex.org/W2554479252","https://openalex.org/W2572174216","https://openalex.org/W2587048937","https://openalex.org/W2615301036","https://openalex.org/W2761508212","https://openalex.org/W2763706377","https://openalex.org/W2767343890","https://openalex.org/W2791043965","https://openalex.org/W2891215230","https://openalex.org/W2893824814","https://openalex.org/W2897230620","https://openalex.org/W2900773301","https://openalex.org/W2911812451","https://openalex.org/W2948046941","https://openalex.org/W2948141873","https://openalex.org/W2955644682","https://openalex.org/W2979972034","https://openalex.org/W2995440672","https://openalex.org/W3003540174","https://openalex.org/W3022500223","https://openalex.org/W3030448313","https://openalex.org/W3043895034","https://openalex.org/W3046154468","https://openalex.org/W3080682266","https://openalex.org/W3084494759","https://openalex.org/W3085860981","https://openalex.org/W3087319099","https://openalex.org/W3087464965","https://openalex.org/W3091399767","https://openalex.org/W3105911547","https://openalex.org/W3112034248","https://openalex.org/W3115703564","https://openalex.org/W3118110474","https://openalex.org/W3120741760","https://openalex.org/W3128803455","https://openalex.org/W3132116659","https://openalex.org/W3165611200","https://openalex.org/W3172913451","https://openalex.org/W3174658350","https://openalex.org/W3182659576","https://openalex.org/W3214324289","https://openalex.org/W4232759851","https://openalex.org/W4286210103","https://openalex.org/W4311610526","https://openalex.org/W4327613841","https://openalex.org/W4360991857","https://openalex.org/W4360992337","https://openalex.org/W4363673745","https://openalex.org/W4366189922","https://openalex.org/W4367848890","https://openalex.org/W4376646211","https://openalex.org/W4378083369","https://openalex.org/W4378172459","https://openalex.org/W4379058596","https://openalex.org/W4379106518","https://openalex.org/W4379379380","https://openalex.org/W4379598750","https://openalex.org/W4383371650","https://openalex.org/W4385199630","https://openalex.org/W4386169979","https://openalex.org/W4386200638","https://openalex.org/W4388575485"],"related_works":["https://openalex.org/W4408594899","https://openalex.org/W4392680642","https://openalex.org/W3043895034","https://openalex.org/W4380886506","https://openalex.org/W3212717695","https://openalex.org/W4384200034","https://openalex.org/W2885234299","https://openalex.org/W3212518782","https://openalex.org/W4282964937","https://openalex.org/W4229069155"],"abstract_inverted_index":{"Targeting":[0,49],"PD-L1":[1,50,82,243],"via":[2,51,252],"monospecific":[3,244],"antibodies":[4,53],"has":[5],"shown":[6,235],"durable":[7,27,72],"clinical":[8,17,28,142,181,205],"benefits":[9,29],"and":[10,30,66,112,114,121,131,162,197,216,231],"long-term":[11,31],"remissions":[12,32],"where":[13],"patients":[14,44,76,222],"exhibit":[15],"no":[16],"cancer":[18,47,108],"signs":[19],"for":[20,107],"many":[21],"years":[22],"after":[23],"treatment.":[24],"However,":[25,227],"the":[26,71,184,211,229],"by":[33],"anti-PD-L1":[34],"monotherapy":[35],"have":[36,90,134,234],"been":[37,91,135],"limited":[38],"to":[39,55,63,93,175,242,256],"a":[40],"small":[41],"fraction":[42],"of":[43,87,104,210],"with":[45,223],"certain":[46],"types.":[48],"bispecific":[52],"(referred":[54],"as":[56,151],"anti-PD-L1-based":[57,88,105,126,170,212,246],"bsAbs)":[58],"which":[59],"can":[60],"simultaneously":[61],"bind":[62],"both":[64,129],"co-inhibitory":[65,130],"co-stimulatory":[67,132],"molecules":[68,133],"may":[69,248],"increase":[70],"antitumor":[73,219],"responses":[74],"in":[75,110,119,122,137,141,166,180,221],"who":[77],"would":[78],"not":[79],"benefit":[80],"from":[81,204],"monotherapy.":[83],"A":[84],"growing":[85],"number":[86],"bsAbs":[89,106,127,171,213,233,247],"developed":[92],"fight":[94],"against":[95],"this":[96],"deadly":[97],"disease.":[98],"This":[99],"review":[100],"summarizes":[101],"recent":[102],"advances":[103],"immunotherapy":[109],"patents":[111],"literatures,":[113],"discusses":[115],"their":[116],"anti-tumor":[117],"efficacies":[118],"vitro":[120],"vivo.":[123],"Over":[124],"50":[125],"targeting":[128],"investigated":[136],"biological":[138],"testing":[139],"or":[140,258],"trials":[143,206],"since":[144,228],"2017.":[145],"At":[146],"least":[147],"eleven":[148],"proteins,":[149],"such":[150],"CTLA-4,":[152],"LAG-3,":[153],"PD-1,":[154],"PD-L2,":[155],"TIM-3,":[156],"TIGIT,":[157],"CD28,":[158],"CD27,":[159],"OX40,":[160],"CD137,":[161],"ICOS,":[163],"are":[164,172],"involved":[165],"these":[167,260],"investigations.":[168],"Twenty-two":[169],"being":[173],"evaluated":[174],"treat":[176],"various":[177],"advanced":[178,224],"cancers":[179],"trials,":[182],"wherein":[183],"indications":[185],"include":[186],"NSCLC,":[187],"SNSCLC,":[188],"SCLC,":[189],"PDA,":[190],"MBNHL,":[191],"SCCHN,":[192],"UC,":[193],"EC,":[194],"TNBC,":[195],"CC,":[196],"some":[198],"other":[199],"malignancies.":[200],"The":[201],"released":[202],"data":[203],"indicated":[207],"that":[208],"most":[209],"were":[214],"well-tolerated":[215],"showed":[217],"promising":[218],"efficacy":[220],"solid":[225],"tumors.":[226],"approved":[230],"investigational":[232],"much":[236],"more":[237],"significant":[238],"adverse":[239,261],"reactions":[240],"compared":[241],"antibodies,":[245],"be":[249],"further":[250],"optimized":[251],"molecular":[253],"structure":[254],"modification":[255],"avoid":[257],"reduce":[259],"reactions.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-01-18T00:00:00"}